BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26218852)

  • 1. Effects of cortisol administration on craving in heroin addicts.
    Walter M; Bentz D; Schicktanz N; Milnik A; Aerni A; Gerhards C; Schwegler K; Vogel M; Blum J; Schmid O; Roozendaal B; Lang UE; Borgwardt S; de Quervain D
    Transl Psychiatry; 2015 Jul; 5(7):e610. PubMed ID: 26218852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Oxytocin on Withdrawal, Craving and Stress Response in Heroin-Dependent Patients: A Randomized, Double-Blind Clinical Trial.
    Moeini M; Omidi A; Sehat M; Banafshe HR
    Eur Addict Res; 2019; 25(1):41-47. PubMed ID: 30630161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.
    Hurd YL; Spriggs S; Alishayev J; Winkel G; Gurgov K; Kudrich C; Oprescu AM; Salsitz E
    Am J Psychiatry; 2019 Nov; 176(11):911-922. PubMed ID: 31109198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of heroin on negative emotional processing: relation of amygdala activity and stress-related responses.
    Schmidt A; Borgwardt S; Gerber H; Wiesbeck GA; Schmid O; Riecher-Rössler A; Smieskova R; Lang UE; Walter M
    Biol Psychiatry; 2014 Aug; 76(4):289-96. PubMed ID: 24314348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence.
    Gerber H; Borgwardt SJ; Schmid O; Gerhard U; Joechle W; Riecher-Rössler A; Wiesbeck GA; Walter M
    Eur Addict Res; 2012; 18(3):116-23. PubMed ID: 22286020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Jitai tablet, a traditional Chinese medicine, on plasma adrenocorticotropic hormone and cortisol levels in heroin addicts during abstinence.
    Fan HY; Sun L; Li XX; Zhou SB; Liang JC; Yan BY; Li Y; Deng YP
    J Altern Complement Med; 2014 Jul; 20(7):527-34. PubMed ID: 24786196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of intravenous heroin on the hypothalamic-pituitary-adrenal axis response: a controlled trial.
    Walter M; Gerber H; Kuhl HC; Schmid O; Joechle W; Lanz C; Brenneisen R; Schächinger H; Riecher-Rössler A; Wiesbeck GA; Borgwardt SJ
    J Clin Psychopharmacol; 2013 Apr; 33(2):193-8. PubMed ID: 23422375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrodotoxin reduces cue-induced drug craving and anxiety in abstinent heroin addicts.
    Shi J; Liu TT; Wang X; Epstein DH; Zhao LY; Zhang XL; Lu L
    Pharmacol Biochem Behav; 2009 Jun; 92(4):603-7. PubMed ID: 19268686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts.
    Shi J; Jun W; Zhao LY; Xue YX; Zhang XY; Kosten TR; Lu L
    Eur J Pharmacol; 2009 Aug; 615(1-3):108-12. PubMed ID: 19470385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts.
    Shi J; Li SX; Zhang XL; Wang X; Le Foll B; Zhang XY; Kosten TR; Lu L
    Am J Drug Alcohol Abuse; 2009; 35(5):267-72. PubMed ID: 19591065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma cortisol levels, withdrawal symptoms and craving in abstinent and treated heroin addicts.
    Nava F; Caldiroli E; Premi S; Lucchini A
    J Addict Dis; 2006; 25(2):9-16. PubMed ID: 16785214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid detoxification of heroin dependence by buprenorphine.
    Liu ZM; Cai ZJ; Wang XP; Ge Y; Li CM
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):112-4. PubMed ID: 10072959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a single 50% extra dose of methadone on heroin craving and mood in lower- versus higher-dose methadone patients.
    Strasser J; Wiesbeck GA; Meier N; Stohler R; Dürsteler-Macfarland KM
    J Clin Psychopharmacol; 2010 Aug; 30(4):450-4. PubMed ID: 20571436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study.
    Woolley JD; Arcuni PA; Stauffer CS; Fulford D; Carson DS; Batki S; Vinogradov S
    Psychopharmacology (Berl); 2016 Jul; 233(13):2571-80. PubMed ID: 27137199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalizing effect of heroin maintenance treatment on stress-induced brain connectivity.
    Schmidt A; Walter M; Gerber H; Seifritz E; Brenneisen R; Wiesbeck GA; Riecher-Rössler A; Lang UE; Borgwardt S
    Brain; 2015 Jan; 138(Pt 1):217-28. PubMed ID: 25414039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subjective dimensions of heroin urges: influence of heroin-related and affectively negative stimuli.
    Sherman JE; Zinser MC; Sideroff SI; Baker TB
    Addict Behav; 1989; 14(6):611-23. PubMed ID: 2618844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced responses to heroin-cue-induced craving in the dorsal striatum: effects of long-term methadone maintenance treatment.
    Wang Y; Wang H; Li W; Zhu J; Gold MS; Zhang D; Wang L; Li Y; Yan X; Cheng J; Li Q; Wang W
    Neurosci Lett; 2014 Oct; 581():120-4. PubMed ID: 25157798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial stress enhances non-drug-related positive memory retrieval in male abstinent heroin addicts.
    Zhao LY; Shi J; Zhang XL; Lu L
    Neurosci Lett; 2010 Nov; 485(1):16-20. PubMed ID: 20732384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial.
    Morabbi MJ; Razaghi E; Moazen-Zadeh E; Safi-Aghdam H; Zarrindast MR; Vousoghi N; Akhondzadeh S
    Int Clin Psychopharmacol; 2018 Mar; 33(2):111-119. PubMed ID: 29064909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.